Paper41579307
A case of bucillamine-induced membranous nephropathy presenting with acute kidney injury and requiring hemodialysis.
Otani H and 16 others. CEN Case Rep, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. A case of bucillamine-induced membranous nephropathy presenting with acute kidney injury and requiring hemodialysis. Papers, record 41579307. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41579307
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A case of bucillamine-induced membranous nephropathy presenting with acute kidney injury and requiring hemodialysis.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acute Kidney Injury | Major topic |
| Glomerulonephritis, Membranous | Major topic |
| Renal Dialysis | Major topic |
| Cysteine | Major topic |
| Humans | |
| Male | |
| Aged | |
| Proteinuria | |
| Biopsy | |
| Arthritis, Rheumatoid | |
| Kidney | |
| Microscopy, Electron |
Source PubMed
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19571279 | M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19571279 | PubMed |
| 2 | 8995742 | IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. | Kidney Int | 1997 | https://conductscience.org/library/papers/8995742 | PubMed |
| 3 | 34370109 | Correction to: Kidney biopsy guidebook 2020 in Japan. | Clin Exp Nephrol | 2021 | https://conductscience.org/library/papers/34370109 | PubMed |
| 4 | 2239933 | Adult minimal change glomerulopathy with acute renal failure. | Am J Kidney Dis | 1990 | https://conductscience.org/library/papers/2239933 | PubMed |
| 5 | 39249508 | Clinicopathological characteristics of neural epidermal growth factor-like 1 protein-associated membranous glomerulonephritis. | Virchows Arch | 2025 | https://conductscience.org/library/papers/39249508 | PubMed |
| 6 | 31901340 | Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. | Kidney Int | 2020 | https://conductscience.org/library/papers/31901340 | PubMed |
| 7 | 34846624 | Use of biologic agents and methotrexate improves renal manifestation and outcome in patients with rheumatoid arthritis: a retrospective analysis. | Clin Exp Nephrol | 2022 | https://conductscience.org/library/papers/34846624 | PubMed |
| 8 | 31037495 | Membranous nephropathy caused by rheumatoid arthritis. | CEN Case Rep | 2019 | https://conductscience.org/library/papers/31037495 | PubMed |
| 9 | 37069980 | Neural Epidermal Growth Factor-Like 1-Positive Membranous Nephropathy With Rheumatoid Arthritis. | Kidney Int Rep | 2023 | https://conductscience.org/library/papers/37069980 | PubMed |
| 10 | 38596642 | NELL1 membranous nephropathy: clinical associations provide mechanistic clues. | Front Nephrol | 2024 | https://conductscience.org/library/papers/38596642 | PubMed |
| 11 | 39990895 | NELL-1-Associated Membranous Nephropathy Induced by Long-Term Penicillamine Treatment in a Patient With Wilson's Disease. | Kidney Int Rep | 2025 | https://conductscience.org/library/papers/39990895 | PubMed |
| 12 | 16685139 | Outcome and treatment of bucillamine-induced nephropathy. | Nephron Clin Pract | 2006 | https://conductscience.org/library/papers/16685139 | PubMed |
| 13 | 40050703 | Bucillamine-induced membranous nephropathy versus primary membranous nephropathy: comparing pathological features and kidney prognosis. | Sci Rep | 2025 | https://conductscience.org/library/papers/40050703 | PubMed |
| 14 | 33606126 | Kidney biopsy guidebook 2020 in Japan. | Clin Exp Nephrol | 2021 | https://conductscience.org/library/papers/33606126 | PubMed |
| 15 | 37547509 | Adding Cases to the Study of Bucillamine-Associated Neural Epidermal Growth Factor-Like1-Positive Membranous Nephropathy. | Kidney Int Rep | 2023 | https://conductscience.org/library/papers/37547509 | PubMed |
| 16 | 11920335 | Bucillamine induces membranous glomerulonephritis. | Am J Kidney Dis | 2002 | https://conductscience.org/library/papers/11920335 | PubMed |
| 17 | 33344486 | Secondary Membranous Nephropathy. A Narrative Review. | Front Med (Lausanne) | 2020 | https://conductscience.org/library/papers/33344486 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41579307
GET https://conductscience.org/api/papers/v1/41579307/authors